{"member_organisations": "EFPIA \nNational pharmaceutical associations", "identification_number": "726065718920-12", "fields_of_interest": "General and Institutional Affairs, Economy, finance and the euro, Trade, Competition, Consumers, International co-operation and development, Customs, Enlargement, Employment and Social Affairs, Business and Industry, Environment, Taxation, Research and innovation, External Relations, Public Health", "head_office_address": "2000 Hillswood Drive", "full_time_equivalent_fte": "1,5", "person_with_legal_responsibility": "Daniel Schulze", "inter_groups": "", "financial_year_start_date": "01/04/2017", "grants": "", "head_office_country": "United Kingdom", "eu_initiatives": "All relevant pharmaceutical and health care initiatives, including Falsified Medicines Directive, Organ supply Directive, European Commission Incentives Review, Member State collaboration in the area of medicines pricing, EUnetHTA, orphan disease legislation, European Medicines Agency and regulatory policy, etc.", "organisation_name": "Astellas Pharma Europe Limited (APEL)", "belgium_office_post_code": "1070", "number_of_persons_involved": "2", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "belgium_office_address": "Astellas Pharma SA Parc Scientifique Erasme Square Marie Curie 50 (Maurice Careme), Batiment 5, 1er etage", "subsection": "Companies & groups", "belgium_office_phone": "(+32)25580710", "number_of_ep_accredited_persons": "", "overall_budget_turnover_as_a_range": "", "belgium_office_city": "Bruxelles", "persons_accredited_for_access_to_european_parliament_premises": "", "estimate_of_costs_absolute_amount": "", "registration_date": "24/09/2015", "website_address": "http://www.astellas.eu", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Chertsey", "membership": "EFPIA \nNational pharmaceutical associations", "head_office_post_code": "KT16 0RS", "goals__remit": "Providing high quality medicines in areas of high unmet medical need", "industry_forums": "", "head_office_phone": "(+44)2033798222", "level_of_interest": "global", "relevant_communication": "We run a European Roundtable on combatting hospital infections with C-Difficile. All of our other engagement is currently through the European Federation of Pharmaceutical industries and Associations.", "financial_year_end_date": "01/03/2018", "estimate_of_costs_as_a_range": "200000-299999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Corporation", "person_in_charge_of_eu_relations": "Barbara McLaughlan", "customers": "", "belgium_office_post_box": "", "position": "Director Government Affairs EMEA"}